EMA agrees with UK: no indication that AstraZeneca vaccine causes blood clots
The European Medicines Agency (EMA) remains “firmly convinced” that the benefits of the AstraZeneca vaccine against Covid-19 outweigh the risks of side effects and has so far found no “evidence” to show that cases of thrombosis recorded in people who have received this vaccine are related to its administration.
This has been assured by the managing director of the EMA, Emer Cooke, in a press conference in which she explained that the organization is evaluating "in depth" the cases of clots that have been detected by the Member States to determine if they are effectively related to the AstraZeneca vaccine or if they are a “coincidence”.
The EMA will reach a final conclusion in this regard on Thursday, but Cooke has repeated the message that the institution has already transmitted on several occasions since last week, that several countries reported cases of thrombosis in people previously vaccinated with this vaccine, and a dozen of them, among others Spain, Germany, France or Italy, decided to temporarily paralyze the injections.
Other articles that may interest you...
"We are still firmly convinced that the benefits of the AstraZeneca vaccine to prevent Covid-19 with its associated risks of hospitalization outweigh the risks of side effects," she said. "At present there is no indication that vaccination has caused these conditions."